ACURX PHARMACEUTICALS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.34 USD | +4.46% |
|
+4.93% | -38.90% |
Chart calendar Acurx Pharmaceuticals, Inc.
abf0613957f67b4c72b7c890f5.OZo9Rq22TAlvMQEJgAKr52ehSLcUUvA1lDER6Y6XtFg.CK54DMfeO2YjU0xm31TzqwP2MsN-YJNl2wFhi77jwXVA3m0_7_o7bCN3UA~21a404973865c3c6a89a147aa0797179
Upcoming events on Acurx Pharmaceuticals, Inc.
Past events on Acurx Pharmaceuticals, Inc.
| 17/06/2024 15:00 | Annual General Meeting |
| 15/05/2024 13:00 | Q1 2024 Earnings Call |
| 15/05/2024 12:01 | Q1 2024 Earnings Release |
| 14/05/2024 | EF Hutton Investor Conference |
| 30/04/2024 07:30 | European Society of Clinical Microbiology and Infectious Diseases Congress - Kevin Garey |
| 28/04/2024 11:00 | European Society of Clinical Microbiology and Infectious Diseases Congress - Poster #P2327 |
| 08/04/2024 19:30 | LD Micro Invitational Conference |
| 18/03/2024 12:00 | Q4 2023 Earnings Call |
| 18/03/2024 11:01 | Q4 2023 Earnings Release |
| 01/02/2024 16:40 | Microcap Conference - Session 2 |
| 31/01/2024 19:00 | Microcap Conference |
| 17/01/2024 | Gulf Coast Consortia Antimicrobial Resistance Conference |
| 11/01/2024 20:00 | JPMorgan Healthcare Conference |
| 14/11/2023 13:00 | Q3 2023 Earnings Call |
| 14/11/2023 12:01 | Q3 2023 Earnings Release |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 14/08/2023 13:00 | Q2 2023 Earnings Call |
| 14/08/2023 12:01 | Q2 2023 Earnings Release |
| 12/07/2023 17:35 | Emerging Growth Conference |
| 20/06/2023 14:30 | Maxim Group Virtual Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -12,8 -14,2 9.68% | -12,1 -12,6 4.27% | -14,6 -12,7 -14.4% | -17,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -12,7 -14,1 9.73% | -12,1 -12,8 5.39% | -14,6 -12,8 -13.77% | -17,4 |
|
Net income Million USD | Released Forecast Spread | -4,60 | -12,7 -14,1 9.73% | -12,1 -12,8 5.39% | -14,6 -12,7 -14.4% | -17,4 |
|
EPS USD | Released Forecast Spread | -0,75 | -1,49 -1,69 11.83% | -1,12 -1,19 5.88% | -1,15 -1,02 -13.3% | -1,03 |
| Announcement Date | 05/04/21 | 16/03/22 | 15/03/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -2,67 -3,38 20.96% | -3,54 -3,50 -1.19% | -3,26 -3,80 14.2% | -2,90 -4,00 27.43% | -3,45 -3,38 -1.95% | -3,11 -3,55 12.25% | -5,11 -3,35 -52.65% | -4,38 -3,80 -15.21% | -3,85 | -3,78 | -5,35 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,67 -3,38 20.96% | -3,54 -3,50 -1.19% | -3,26 -3,95 17.46% | -2,90 -4,00 27.43% | -3,45 -3,38 -1.95% | -3,11 -3,55 12.25% | -5,11 -3,35 -52.65% | -4,38 -3,80 -15.21% | -3,85 | -3,78 | -5,35 | |
|
Net income Million USD | Released Forecast Spread | -2,67 -3,38 20.96% | -2,62 | -3,54 -3,50 -1.19% | -3,26 -3,95 17.46% | -2,90 -4,00 27.43% | -3,45 -3,38 -1.95% | -3,11 -3,55 12.25% | -5,11 -3,35 -52.65% | -4,38 -3,80 -15.21% | -3,85 | -3,78 | -5,35 |
|
EPS USD | Released Forecast Spread | -0,26 -0,33 21.21% | -0,26 | -0,32 -0,34 5.88% | -0,28 -0,35 20% | -0,25 -0,34 26.47% | -0,28 -0,29 3.45% | -0,24 -0,28 14.29% | -0,38 -0,25 -55.1% | -0,28 -0,24 -16.67% | -0,22 | -0,22 | -0,32 |
| Announcement Date | 10/05/22 | 12/08/22 | 10/11/22 | 15/03/23 | 12/05/23 | 11/08/23 | 13/11/23 | 15/03/24 | 14/05/24 | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Acurx Pharmaceuticals, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACXP Stock
- Calendar Acurx Pharmaceuticals, Inc.
